Fertilizers and Agricultural Chemicals

Nexentis Tech

Nexentis Tech released FY2026 Q1 earnings on May 14 (EST) with actual revenue of USD 0 and EPS of USD -10.739

Nexentis Tech released FY2025 Annual Earnings on March 31 (EST) with actual revenue of USD 0 and EPS of USD -34.9551

Nexentis Tech released FY2025 Q4 earnings on March 31 (EST), actual revenue USD -68K, actual EPS USD 0.3347

Nexentis Tech released FY2025 9 Months Earnings on November 13, 2025 (EST), with actual revenue of USD 68K and EPS of USD -59.2775

Nexentis Tech released FY2024 Q3 earnings on November 13 (EST), actual revenue USD 9K, actual EPS USD -95.182

Nexentis Tech released FY2024 9-month earnings on November 13 (EST), actual revenue USD 70K, actual EPS USD -215.4438

Nexentis Tech released FY2025 Q3 earnings on November 13 (EST), actual revenue USD 2 K, actual EPS USD 3.1835

Nexentis Tech released FY2025 Q2 earnings on August 14, 2025 (EST) with actual revenue of USD 0 and EPS of USD -44.3856

Nexentis Tech released FY2025 Semi-Annual earnings on August 14 (EST), actual revenue USD 66K, actual EPS USD -131.8262

Nexentis Tech released FY2024 Semi-Annual Earnings on August 14, 2025 (EST) with actual revenue of USD 61K and EPS of USD -119.7015

Nexentis Tech released FY2024 Q2 earnings on August 14 (EST), actual revenue USD 17K, actual EPS USD -56.5617

Nexentis Tech released FY2024 Q1 earnings on May 15 (EST), actual revenue USD 44K, actual EPS USD -63.7

Nexentis Tech released FY2025 Q1 earnings on May 15 (EST) with actual revenue of USD 66 K and actual EPS of USD -18.0754

Nexentis Tech released FY2024 earnings on March 31 (EST), actual revenue USD 0 (forecast USD 8.34 M), actual EPS USD -194.1871

Nexentis Tech released FY2023 Annual Earnings on March 31, 2025 (EST): Actual Revenue USD 263K (Forecast USD 1.68M), Actual EPS USD 0

Nexentis Tech released FY2023 Q4 earnings on March 31 (EST), actual revenue USD 105.38 K, actual EPS USD 0

Nexentis Tech released FY2024 Q4 earnings on March 31 (EST), actual revenue USD -69 K, actual EPS USD -30.1035

InMed Pharmaceuticals

AMPLITECH GROUP INC. USD0.001 S/R 20/11/26 SER B

Amesite

CN Energy

AMPLITECH GROUP INC. COM USD0.001 (S/R 18/07/2026)

NextNRG

Meiwu Tech

Generation Income Properties

MetaVia

OceanPal

NXTS

Nexentis Announces MitoCareX Bio Achieves Key R&D Milestone, Generating a Substantially Improved Hit Molecule on the Path to Pre-Clinical Development | NXTS Stock News

StockTitan

Nexentis Announces MitoCareX Bio Achieves Key R&D Milestone, Generating a Substantially Improved Hit Molecule on the Path to Pre-Clinical Development | NXTS Stock News

Nexentis Technologies Announces Optimization of Hit Molecule at MitoCareX Bio Representing Key Drug Discovery Milestone | NXTS Stock News

Nexentis Technologies Announces Optimization of Hit Molecule at MitoCareX Bio Representing Key Drug Discovery Milestone | NXTS Stock News

Nexentis Tech pre-market down 9.93%; Phoenix Asia pre-market up 86.31%; Robo.ai pre-market up 74.81%; Innodata pre-market up 50.80%

Price Alert

Phoenix Asia

Robo.ai

Innodata

Pre-market hot trades in US stocks: Nexentis Tech fell nearly 10% in pre-market trading, as patent approval fails to alleviate market concerns about risks

Nexentis Technologies Inc. announced that its subsidiary, MitoCareX Bio Ltd., received U.S. trademark registration for its algorithm platform, MITOLINE™. This platform aids in mitochondrial drug discovery by enabling 3D modeling of mitochondrial carrier proteins. CEO David Palach emphasized the importance of this trademark in enhancing their discovery engine's identity. MitoCareX aims to develop therapies for challenging cancers and metabolic diseases, leveraging MITOLINE™ for rapid identification of small molecule scaffolds. Nexentis also invests in renewable energy projects in Europe and holds a significant stake in Save Foods Ltd.

Nexentis Technologies Announces U.S. Trademark Registration Approval for MitoCareX’s Algorithm Platform MITOLINE™ | NXTS Stock News

Nexentis Technologies Announces 1-for-7 Reverse Stock Split

Tip Ranks

Nexentis Technologies Announces 1-for-7 Reverse Stock Split

Nexentis Technologies Inc. Launches New Corporate Website, Showcasing Innovative AI-Driven Biotech Platform | NXTS Stock News

Nexentis Technologies Inc. Launches New Corporate Website, Showcasing Innovative AI-Driven Biotech Platform | NXTS Stock News

NITO

N2OFF fell 10.66%; Kediwa Agricultural Technology fell 0.11%, with a transaction volume of USD 146 million; Meisheng fell 2.77%, with a transaction volume of USD 110 million; CF Industries fell 1.22%, with a transaction volume of USD 943.8 million; Nutrien rose 0.46%, with a market value of USD 34.6 billion

N2OFF

U.S. stock market midday update: N2OFF drops over 10% with a surge in trading volume, market sentiment fluctuations attract attention

ACLX

BHAT

Overview of the US Stock Market The current market shows a clear trend of differentiation, with technology stocks and biotechnology stocks performing particularly well. The strong rise of Arcellx has attracted market attention, with an increase of 77.55% and significantly expanded trading volume, indicating active capital involvement. Meanwhile, Signing Day Sports also performed well, with an increase of 54.44%, achieving an astonishing rise of 315.18% in just 10 days, attracting a large amount of short-term capital. Overall, market sentiment is leaning towards active, with a noticeable increase in short-term enthusiasm. The most volatile stock in the last hour, Arcellx (ACLX), performed impressively in trading, with an increase of 77.55% and a significant increase in trading volume, showing strong capital demand. The strong performance of this stock seems to have driven the overall rise of the biotechnology sector, with market sentiment soaring. Strong stocks: 1. Guardforce AI (GFAI): up 29.02%, with significantly increased trading volume, and the market is full of expectations for its future development. 2. VenHub Global (VHUB): up 25.63%, with noticeable capital inflow and continued short-term enthusiasm. 3. Global Interactive Tech (GITS): up 22.76%, with increased recent activity attracting a lot of short-term capital

- The US stock market is currently exhibiting a clear trend of differentiation, particularly within technology and biotechnology sectors.  
- Notable performers include Arcellx, which rose by 77.55%, and Signing Day Sports, surging by 54.44%, attracting significant short-term investments.  
- Conversely, several stocks are under pressure, with Blue Hat dropping 46.28%, indicating a downturn in market sentiment.

Arcellx

Signing Day Sports

Blue Hat Interactive Ent Tech

20/20 Biolabs

Novabay Pharmac

WeShop

Gen Digital - Rights

Guardforce AI

VenHub Global

Real Messenger

Abits

Global Interactive Tech

Diginext

Clean Energy Tech

Park Ha Biological Tech

Star Fashion Culture

Planet Green

Beneficient

Lavoro

Neo-Concept

Starfighters Space

Tandem Diabetes

Zeo Energy

Novo Nordisk AS

Algorhythm

Baiya

Antelope Enterprise

Founder

Atomera

Profusa

Homestolife

DevvStream

Knorex

Edesa Biotech

ImmunityBio

DirectBooking Tech

Oriental Culture

Interactive Strength

Critical Metals

Smart Logistics Global

Troops

Ringcentral

Planet Image

GIBO

Solana

CVRx

MongoDB

Faraday Future Intelligent Electric

Rich Sparkle

Namib Minerals

Everbright Digital

Nasus Pharma

Datadog

Cogent Communications

TRAILBLAZER MERGER CORP I USD0.0001 CL A (S/R21/04/2028)

CrowdStrike

Purple Biotech

Mangoceuticals

KLX Energy Services

DNOW

Harmony Biosciences

Zscaler

Advanced Biomed

Evolution Metals & Tech

AIOS Tech

AppLovin

Direct Digital

Snowflake

Satellogic

Brand Engagement Network

TMD Energy

Regencell Bioscience

CloudFlare

Wayfair

Apimeds Pharmaceuticals US

Anghami

XChange Tec.Inc

SABRE

Opendoor Tech Series K - CW26

Olenox Industries

Atlassian

Funko

NuScale Power

AST SpaceMobile

Dermata Therapeutics

Expedia

Rackspace Tech

Monday.com

Workday

Pegasystems

Shopify 

American Express

Off The Hook YS

Capital One Financial

Zoom Communications

US Stock Movement Update: Arcellx surged 77.55%, Signing Day Sports rose 54.44%, Blue Hat Interactive Ent Tech fell 46.28%

Nexentis Tech(NXTS.US)

Nexentis Announces MitoCareX Bio Achieves Key R&D Milestone, Generating a Substantially Improved Hit Molecule on the Path to Pre-Clinical Development | NXTS Stock News

Nexentis Technologies Announces Optimization of Hit Molecule at MitoCareX Bio Representing Key Drug Discovery Milestone | NXTS Stock News

Pre-market hot trades in US stocks: Nexentis Tech fell nearly 10% in pre-market trading, as patent approval fails to alleviate market concerns about risks

Nexentis Technologies Announces U.S. Trademark Registration Approval for MitoCareX’s Algorithm Platform MITOLINE™ | NXTS Stock News

Nexentis Technologies Announces 1-for-7 Reverse Stock Split

Nexentis Technologies Inc. Launches New Corporate Website, Showcasing Innovative AI-Driven Biotech Platform | NXTS Stock News

U.S. stock market midday update: N2OFF drops over 10% with a surge in trading volume, market sentiment fluctuations attract attention

US Stock Movement Update: Arcellx surged 77.55%, Signing Day Sports rose 54.44%, Blue Hat Interactive Ent Tech fell 46.28%